100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothGliclazide 80mg + Metformin 500mg + Voglibose 0.3mg
Our Recommendation
Gliclaglaze Trio 0.3/500/80mg Tablet SR 15s
Steris Healthcare Pvt. Ltd.
116+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Customers also bought
More About Emvizid 0.3 Tablet SR
Side Effects
Side effects of Emvizid Tablet SRThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Emvizid Nausea Hypoglycemia (low blood glucose level)Abdominal pain Constipation
How to use
How to use Emvizid Tablet SRFollow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Emvizid 0.3 Tablet SR is to be taken with food.
How it works
How Emvizid Tablet SR works Emvizid 0.3 Tablet SR is a combination of three antidiabetic medicines:.
Unsafe: Avoid consuming alcohol with Emvizid 0.3 Tablet SR as it is deemed unsafe.
Emvizid 0.3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Emvizid 0.3 Tablet SR should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Emvizid 0.3 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Emvizid 0.3 Tablet SR may be needed. Doctor consultation is advised.Use of Emvizid 0.3 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Emvizid 0.3 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Emvizid 0.3 Tablet SR may be needed. Doctor consultation is advised.Emvizid 0.3 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Manufacturer Address
faraz complex , ramesh park Laxmi Nagar , New delhi
References
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)
Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003 (12 Mar. 2019)
Gliclazide+Metformin+Voglibose (21 Oct. 2021)
American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S98-S110 (21 Oct. 2021)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Top Selling Medicines
Top Selling Devices
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100
Download Now
